Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer: A Phase 2 Trial

IMPORTANCE: Patients with oligometastatic non–small cell lung cancer (NSCLC) may benefit from locally ablative therapy (LAT) such as surgery or stereotactic radiotherapy. Prior studies were conducted before the advent of immunotherapy, and a strong biological rationale for the use of immunotherapy e...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Oncol
Main Authors: Bauml, Joshua M., Mick, Rosemarie, Ciunci, Christine, Aggarwal, Charu, Davis, Christiana, Evans, Tracey, Deshpande, Charuhas, Miller, Linda, Patel, Pooja, Alley, Evan, Knepley, Christina, Mutale, Faith, Cohen, Roger B., Langer, Corey J.
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2019
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6624820/
https://ncbi.nlm.nih.gov/pubmed/31294762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.1449
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker